Matthias von Herrath

Matthias von Herrath

Company: Novo Nordisk

Job title: VP & Senior Medical Officer


Panel Discussion: Improving Strategies for Long Term Graft Acceptance of Allogeneic Therapies 11:30 am

Exploring the regulations around how cells can be modified How much do you need to modify cells? Moving towards improving immune modulatory regimens that don’t require long-term immune suppressionRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.